Ginseng HRG80 in Stress and Fatigue
Study of the Efficacy of Panax Ginseng Herbal Preparation HRG80 for Prevention and Mitigation of the Symptoms of Stress in Healthy Subjects
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Yerevan, Armenia
- Sports Medicine and Anti-Doping Service Republican Centre
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Individuals experiencing at least one symptom of stress and fatigue during 8 hours of mental work with a computer.
- Men and women ages 18-65 (all races and ethnicities)
- Able to understand and participate in an 11-week study
Exclusion Criteria:
- Taking medicine or dietary supplements which may have potential effects on cognitive function
- Consuming more than 1 cup of coffee daily (in the morning).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: HRG80 Panax ginseng
Panax ginseng standardized to 63.4 mg of total ginsenosides taken orally once daily in the morning after a meal.
|
Panax ginseng containing 63.4 mg ginsenosides
|
|
Active Comparator: Panax ginseng
Panax ginseng standardized to 19.6 mg of total ginsenosides taken orally once daily in the morning after a meal.
|
Panax ginseng containing 19.6 mg ginsenosides
|
|
Placebo Comparator: Placebo
Placebo capsule containing brown sugar and rice flour, taken orally once daily in the morning after a meal.
|
800 mg excipient
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Perceived Stress Scale (PSS) from baseline to the last day of treatment
Time Frame: Two weeks
|
The Perceived Stress Scale is a psychological instrument for measuring the perception of stress by an individual.
Scores from 0-13 indicate low stress, 14-26 is considered moderate stress, and scores from 27-40 indicate high perceived stress.
The primary outcome is the change in the baseline PSS score for HRG80 versus standard Panax ginseng and placebo.
|
Two weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Areg Hovhannisyan, PhD, Dr Sci, Sports Medicine and Anti-Doping Service Republican Centre
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- EP-1005
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.